Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PRKAR1A Antikörper

PRKAR1A Reaktivität: Human WB, IHC, IF Wirt: Maus Monoclonal 6C7 unconjugated
Produktnummer ABIN2729578
  • Target Alle PRKAR1A Antikörper anzeigen
    PRKAR1A (Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1) (PRKAR1A))
    Reaktivität
    • 46
    • 18
    • 16
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 43
    • 3
    Maus
    Klonalität
    • 44
    • 2
    Monoklonal
    Konjugat
    • 29
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PRKAR1A Antikörper ist unkonjugiert
    Applikation
    • 39
    • 18
    • 16
    • 5
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
    Aufreinigung
    Purified from mouse ascites fluids by affinity chromatography
    Immunogen
    Full-length protein expressed in 293T cell transfected with human PRKAR1A expression vector
    Klon
    6C7
    Isotyp
    IgG1
    Top Product
    Discover our top product PRKAR1A Primärantikörper
  • Applikationshinweise
    WB 1:2000, IHC 1:50, IF 1:100,
    Kommentare

    The concentration of the product may vary between diferrent lots.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5-1.0 mg/mL
    Buffer
    PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Graham, Lackner, Terracciano, González-Cantú, Maleszewski, Greipp, Simon, Torbenson: "Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion." in: Hepatology (Baltimore, Md.), Vol. 68, Issue 4, pp. 1441-1447, (2019) (PubMed).

    Graham, Terracciano, Meves, Vanderboom, Dasari, Yeh, Torbenson, Cruise: "Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 29, Issue 6, pp. 607-15, (2018) (PubMed).

    Sousa, Gomez, Diniz, Bernardes, Soares, Brito, Liu, Pontes, Stratakis, Gomes: "Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors." in: Endocrine-related cancer, Vol. 22, Issue 3, pp. 399-408, (2015) (PubMed).

    Maleszewski, Larsen, Kip, Castonguay, Edwards, Carney, Kipp: "PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors." in: The American journal of surgical pathology, Vol. 38, Issue 8, pp. 1079-87, (2014) (PubMed).

    Wells, OReilly, Szul, Sullivan, Handley, Garrett, McNicholas, Roda, Miller, Tal-Singer, Gaggar, Rennard, Jackson, Blalock: "An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease." in: American journal of respiratory and critical care medicine, Vol. 190, Issue 1, pp. 51-61, (2014) (PubMed).

    Shajahan-Haq, Cook, Schwartz-Roberts, Eltayeb, Demas, Warri, Facey, Hilakivi-Clarke, Clarke: "MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer." in: Molecular cancer, Vol. 13, pp. 239, (2014) (PubMed).

    Zhao, Li, Wohlford-Lenane, Agnihothram, Fett, Zhao, Gale, Baric, Enjuanes, Gallagher, McCray, Perlman: "Rapid generation of a mouse model for Middle East respiratory syndrome." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Issue 13, pp. 4970-5, (2014) (PubMed).

    Tian, Jiang, Tamosiuniene, Sung, Qian, Dhillon, Gera, Farkas, Rabinovitch, Zamanian, Inayathullah, Fridlib, Rajadas, Peters-Golden, Voelkel, Nicolls: "Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension." in: Science translational medicine, Vol. 5, Issue 200, pp. 200ra117, (2013) (PubMed).

    Wang, Henry, Distefano, Wang, Räikkönen, Mönkkönen, Tanaka, Morita: "Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human V?2V?2 T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 3, pp. 1029-42, (2013) (PubMed).

  • Target
    PRKAR1A (Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1) (PRKAR1A))
    Andere Bezeichnung
    PRKAR1A (PRKAR1A Produkte)
    Synonyme
    ACRDYS1 antikoerper, ADOHR antikoerper, CAR antikoerper, CNC antikoerper, CNC1 antikoerper, PKR1 antikoerper, PPNAD1 antikoerper, PRKAR1 antikoerper, TSE1 antikoerper, 1300018C22Rik antikoerper, RIalpha antikoerper, Tse-1 antikoerper, Tse1 antikoerper, RIIA antikoerper, prkar1a antikoerper, zgc:92515 antikoerper, im:7047729 antikoerper, cnc1 antikoerper, pkr1 antikoerper, ppnad1 antikoerper, prkar1 antikoerper, tse1 antikoerper, protein kinase cAMP-dependent type I regulatory subunit alpha antikoerper, protein kinase, cAMP dependent regulatory, type I, alpha antikoerper, protein kinase cAMP-dependent type 1 regulatory subunit alpha antikoerper, protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) a antikoerper, cAMP-dependent protein kinase type I-alpha regulatory subunit pseudogene antikoerper, protein kinase cAMP-dependent type I regulatory subunit alpha S homeolog antikoerper, PRKAR1A antikoerper, Prkar1a antikoerper, prkar1aa antikoerper, LOC707275 antikoerper, prkar1a.S antikoerper
    Molekulargewicht
    43.0 KDa
    Gen-ID
    5573
    NCBI Accession
    NM_212472
    HGNC
    5573
    Pathways
    Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Sie sind hier:
Kundenservice